中國航天萬源(01185.HK)接獲聯交所復牌指引
格隆匯5月24日丨中國航天萬源(01185.HK)公佈,於2021年5月24日,公司接獲一份聯交所函件,其中包含有關公司的以下復牌指引:
(i)刊發上市規則規定的所有未刊發財務業績,並處理任何審核修訂;
(ii)證明公司已遵守上市規則第13.24條;及
(iii)向市場吿知所有重要資料,以供公司股東及投資者評估公司的狀況。
聯交所要求公司補救導致其暫停買賣的問題,並在允許其證券買賣恢復之前以聯交所滿意的方式完全遵守上市規則,為此,公司負有制定其恢復買賣行動計劃的主要責任。聯交所進一步表示,倘公司狀況發生變化,其可能會修改或補充復牌指引。
此外,公司股份繼續停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.